Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 413

1.

Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.

Hayashi M, Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Takeda S, Kodera Y.

J Surg Oncol. 2012 Mar 15;105(4):381-6. doi: 10.1002/jso.22135. Epub 2011 Nov 3.

PMID:
22052684
2.

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.

Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.

Ann Surg Oncol. 2010 Mar;17(3):923-32. doi: 10.1245/s10434-009-0790-0. Epub 2009 Nov 7.

PMID:
19898900
3.

Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.

Liu W, Guan M, Su B, Ye C, Li J, Zhang X, Liu C, Li M, Lin Y, Lu Y.

Cancer Biol Ther. 2010 Jun 1;9(11):862-71. Epub 2010 Jun 26.

PMID:
20364105
4.

Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis.

Kanda M, Nomoto S, Okamura Y, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A.

Int J Oncol. 2009 Sep;35(3):477-83.

PMID:
19639168
5.

Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.

Goeppert B, Schmezer P, Dutruel C, Oakes C, Renner M, Breinig M, Warth A, Vogel MN, Mittelbronn M, Mehrabi A, Gdynia G, Penzel R, Longerich T, Breuhahn K, Popanda O, Plass C, Schirmacher P, Kern MA.

Hepatology. 2010 Dec;52(6):2023-33. doi: 10.1002/hep.23939. Epub 2010 Oct 26.

PMID:
20979053
6.

Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.

Okamura Y, Nomoto S, Kanda M, Li Q, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A.

Cancer Lett. 2010 Mar 28;289(2):170-7. doi: 10.1016/j.canlet.2009.08.013. Epub 2009 Sep 3.

PMID:
19733004
7.

DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.

Hou X, Peng JX, Hao XY, Cai JP, Liang LJ, Zhai JM, Zhang KS, Lai JM, Yin XY.

Ann Surg Oncol. 2014 Nov;21(12):3891-9. doi: 10.1245/s10434-013-3401-z. Epub 2013 Dec 4.

PMID:
24306662
8.

Detection of doublecortin domain-containing 2 (DCDC2), a new candidate tumor suppressor gene of hepatocellular carcinoma, by triple combination array analysis.

Inokawa Y, Nomoto S, Hishida M, Hayashi M, Kanda M, Nishikawa Y, Takeda S, Sugimoto H, Fujii T, Yamada S, Kodera Y.

J Exp Clin Cancer Res. 2013 Sep 14;32:65. doi: 10.1186/1756-9966-32-65.

9.

Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.

Shimizu D, Kanda M, Nomoto S, Oya H, Takami H, Hibino S, Suenaga M, Inokawa Y, Hishida M, Takano N, Nishikawa Y, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.

Oncol Rep. 2014 Mar;31(3):1305-13. doi: 10.3892/or.2013.2939. Epub 2013 Dec 20.

PMID:
24366000
10.

Reduced expression of reelin (RELN) gene is associated with high recurrence rate of hepatocellular carcinoma.

Okamura Y, Nomoto S, Kanda M, Hayashi M, Nishikawa Y, Fujii T, Sugimoto H, Takeda S, Nakao A.

Ann Surg Oncol. 2011 Feb;18(2):572-9. doi: 10.1245/s10434-010-1273-z. Epub 2010 Aug 24.

PMID:
20734148
11.

Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.

Liu W, Gong J, Hu J, Hu T, Sun Y, Du J, Sun C, Guan M, Jiang H, Lu Y.

Urology. 2011 Apr;77(4):1006.e1-7. doi: 10.1016/j.urology.2010.12.010. Epub 2011 Feb 18.

PMID:
21310466
12.

Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis.

Hishida M, Nomoto S, Inokawa Y, Hayashi M, Kanda M, Okamura Y, Nishikawa Y, Tanaka C, Kobayashi D, Yamada S, Nakayama G, Fujii T, Sugimoto H, Koike M, Fujiwara M, Takeda S, Kodera Y.

Int J Oncol. 2013 Jul;43(1):88-94. doi: 10.3892/ijo.2013.1951. Epub 2013 May 20.

PMID:
23695389
13.

Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.

Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS.

Ann Surg Oncol. 2008 Dec;15(12):3494-502. doi: 10.1245/s10434-008-0146-1. Epub 2008 Oct 2.

PMID:
18830757
14.

Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.

Fukai K, Yokosuka O, Chiba T, Hirasawa Y, Tada M, Imazeki F, Kataoka H, Saisho H.

Cancer Res. 2003 Dec 15;63(24):8674-9.

15.

MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.

Xia W, Ni J, Zhuang J, Qian L, Wang P, Wang J.

Int J Biochem Cell Biol. 2016 Feb;71:1-11. doi: 10.1016/j.biocel.2015.11.017. Epub 2015 Dec 2.

PMID:
26646106
16.

Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.

Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K.

J Gastroenterol Hepatol. 2013 Mar;28(3):565-75. doi: 10.1111/j.1440-1746.2012.07271.x.

PMID:
22989374
17.

Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma.

Jung N, Won JK, Kim BH, Suh KS, Jang JJ, Kang GH.

J Korean Med Sci. 2012 Jun;27(6):594-604. doi: 10.3346/jkms.2012.27.6.594. Epub 2012 May 26.

18.

MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.

Tang JT, Wang JL, Du W, Hong J, Zhao SL, Wang YC, Xiong H, Chen HM, Fang JY.

Carcinogenesis. 2011 Aug;32(8):1207-15. doi: 10.1093/carcin/bgr114. Epub 2011 Jun 10.

PMID:
21665895
19.
20.

Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.

Neumann O, Kesselmeier M, Geffers R, Pellegrino R, Radlwimmer B, Hoffmann K, Ehemann V, Schemmer P, Schirmacher P, Lorenzo Bermejo J, Longerich T.

Hepatology. 2012 Nov;56(5):1817-27. doi: 10.1002/hep.25870. Epub 2012 Oct 14.

PMID:
22689435

Supplemental Content

Support Center